Quantcast

Latest Blueprint Medicines Stories

2015-04-08 08:30:31

CAMBRIDGE, Mass., April 8, 2015 /PRNewswire/ -- Blueprint Medicines today announced it will present new preclinical data on its drug candidate BLU-285 in gastrointestinal stromal tumors (GIST), as

2015-03-16 08:31:48

- On track to file IND for BLU-554 and initiate clinical studies by mid-2015 - CAMBRIDGE, Mass., March 16, 2015 /PRNewswire/ -- Blueprint Medicines today announced publication of the discovery

2015-03-03 08:36:00

- Collaboration combines Blueprint Medicines' kinase-focused drug discovery platform with Alexion's experience developing and commercializing therapies for severe and life-threatening disorders -

2014-11-20 12:31:36

- Builds on Company's novel discovery of several kinase fusion genes in cancer - CAMBRIDGE, Mass., Nov.

2014-11-12 08:32:58

-Proceeds to support continued advancement of highly selective kinase inhibitors to genomically defined cancers, including first-in-class FGFR4 and KIT Exon 17 inhibitors- CAMBRIDGE, Mass.,

2014-09-19 08:23:55

--Genomic Data in Study Published in Nature Communications Suggests New Treatment Strategies for These Hard to Treat Women's Reproductive Cancers-- BALTIMORE and CAMBRIDGE, Mass., Sept.

2014-09-10 08:32:36

- Findings and research approach published in Nature Communications - CAMBRIDGE, Mass., Sept.


Word of the Day
cespitose
  • Growing in low tufty patches.
The word 'cespitose' comes from a Latin word meaning 'turf'.
Related